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1001-9 Effect of Free Fatty Acid Inhibition on Left Ventricular 
Function in Diabetic Patients With Coronary Artery 
Disease
Giuseppe M. Rosano, Giuseppe Mercuro, Cristiana Vitale, Barbara Sposato, Massimo 
Fini, San Raffaele Roma, Roma, Italy, University of Cagliari, Cagliari, Italy
In diabetic patients with coronary artery disease free fatty acid blockade with trimetazi-
dine improves myocardial glucose utilization. Aim of the present study was to evaluate
whether the metabolic effect of Trimetazidine on left ventricular function in diabetic
patients with coronary artery disease. We evaluated the effect of chronic administration
of Trimetazidine on left ventricular dimensions and systolic function in 32 patients y (24
males and 8 females, mean (SE) age = 67±6 years) with NIDDM and ischemic cardiomy-
opathy.
Patients were randomized to receive on top of standard therapy either Trimetazidine (20
mg, tds) or Placebo (tds) and were evaluated at baseline and after 6 months.
Demographic data were comparable between the two groups with respect to sex, age,
distribution of CAD, and glicated haemoglobin levels. In the Placebo group, baseline
LVEDD increased from 62.4+1.7 to 63+2.1 mm, while in the Trimetazidine group
decreased from 63.2+2.1 to 58+1.6 mm (p=0.01 compared to baseline). Similarly LVESD
increased from 53+1.3 to 54.2+0.9 mm in the Placebo group and decreased from
52.1+1.5 to 46+1 mm in the Trimetazidine group, respectively (NS).
Compared to baseline, LVEF increased by 5.4±0.5% (p<0.05) in the TMZ group while
remained unchanged in the Placebo group –2.4±1.1% (NS), p<0.01 between groups.
In conclusion, in diabetic patients with ischemic heart disease TMZ added to standard
medical therapy has beneficial effect on LV volumes and on LVEF compared to placebo.
This effect may be related to the effect of TMZ upon cardiac glucose utilization.
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1001-10 Testosterone Replacement Confers a Favourable 
Cytokine Profile in Men With Low Serum Testosterone 
and Coronary Disease
Chris J. Malkin, Peter J. Pugh, Katherine E. Kerry, Richard D. Jones, Dheeraj Kapoor, 
Hugh T. Jones, Kevin S. Channer, Royal Hallamshire Hospital, Sheffield, United 
Kingdom, The University of Sheffield, Sheffield, United Kingdom
Background Men with atherosclerotic coronary disease have lower serum testosterone
(T) levels than men with normal angiograms. T has immune-modulating properties and
replacement therapy inhibits atherogenesis in castrated, male, cholesterol-fed animals.
In-vitro evidence suggests that T suppresses pro-inflammatory cytokines such as tumour
necrosis factor (TNF α) and potentiates the expression of anti-inflammatory cytokines
such as interleukin (IL)-10, these effects may mediate the atheroprotective effect
observed in animals. The effect of T replacement therapy on inflammatory cytokines in
men with coronary disease is explored for the first time in this study.
Methods This was a randomised placebo controlled crossover study of 1 month T
replacement (Sustanon 100) versus placebo in 20 men (age 61 ± 9years) with symptom-
atic androgen deficiency (total T 6.7 ± 2.3 nmol/L (normal range >8.3nmol/L)) and angio-
graphic proven coronary disease (>70% stenosis of > 1 epicardial coronary artery).
Serum cytokines (TNFα, IL-1β and IL-10), cholesterol profiles (total cholesterol, low den-
sity lipoprotein, high density lipoprotein, triglycerides) and hormones (total T and bio-
available T) were recorded at baseline and after treatment from the T and placebo phase.
Results are displayed as mean ± SD. Delta analysis was used to test significance.
Results Compared to placebo, T reduced both TNFα (-4.1 ± 9.1 v 1.5 ± 5.9 pg/ml,
p=0.007) and IL-1β (-0.17 ± 0.3 v 0.2 ± 0.6 pg/ml, p=0.04). An increase in IL-10
approached significance (0.32 ± 2 v –0.87 ± 3.2 pg/ml, p=0.08). There was a trend to
reduction in total cholesterol with T (-0.26 ± 0.5 v –0.005 ± 0.5mmol/L, p=0.1).
Conclusions Testosterone replacement in this cohort shifts the cytokine balance to a
state of reduced inflammation, this may have positive effects on atherosclerotic plaque
biology. Since the prevalence of hypogonadism in men with coronary disease is high
(23%) and the risk of vascular complications and mortality is in part determined by
inflammation. Testosterone may offer prognostic benefit to a large proportion of men with
overt coronary disease.
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1001-11 Lower Doses of Hormone Replacement Therapy Did Not 
Increase hsC-Reactive Protein or F1+2 Levels but 
Improved Flow-Mediated Dilation in Postmenopausal 
Women: A Randomized, Double-Blind, Crossover Study
Kwang K. Koh, Jeong Y. Ahn, Seung H. Han, Mi-Seung Shin, Tae H. Ahn, Eak K. Shin, 
Gachon Medical School, Incheon, South Korea
Objective: The effects of hormone replacement therapy (HRT) can affect many aspects
relevant to cardiovascular disease including vasomotor function, inflammation, and
hemostasis. Recent studies have demonstrated that current doses of HRT exert a mix-
ture of both protective and adverse effects. In the current study, we compared the effects
of lower doses of HRT (L-HRT) and conventional doses of HRT (C-HRT) on a variety of
relevant cardiovascular parameters.
Methods and Results: This randomized, double-blind, crossover study included fifty-
seven women who received micronized progesterone 100 mg with either conjugated
equine estrogen 0.625 mg (C-HRT) or 0.3 mg (L-HRT) daily for 2 months. L-HRT showed
comparable effects to C-HRT on HDL cholesterol and triglyceride levels, but not on LDL
cholesterol levels. C-HRT and L-HRT significantly improved the percent flow-mediated
dilator response to hyperemia from baseline values (both p<0.001) by a similar degree
(p=0.719). C-HRT significantly increased high sensitivity CRP (hsCRP) levels from base-
line values (p<0.001), however, L-HRT did not significantly change hsCRP (p=0.874). C-
HRT and L-HRT significantly decreased antithrombin III from baseline values (p<0.001
and p=0.042, respectively). C-HRT significantly increased prothrombin fragment 1+2
(F1+2) from baseline values (p<0.001), however, L-HRT did not significantly change
F1+2 (p=0.558). Of interest, the effects of C-HRT and L-HRT on hsCRP, antithrombin III,
and F1+2 were significantly different (all p<0.001). C-HRT and L-HRT significantly
reduced plasma PAI-1 antigen levels from baseline values (p=0.002 and p=0.038,
respectively) to a similar degree (p=0.184). *=P<0.05;**=P<0.01;***=P<0.001 vs. Base-
line. Data= mean±SEM or median (25%-75%).
Conclusions: Compared with C-HRT, L-HRT has comparable effects on lipoproteins,
flow-mediated dilation, and PAI-1 antigen levels. However, L-HRT did not increase
hsCRP or F1+2 levels and it decreased antithrombin III less than C-HRT.
Base-1 C-HRT Base-2 L-HRT
hsCRP (mg/dl) 0.08 (0.04-0.17) 0.15 (0.06-0.34)*** 0.08 (0.05-0.25)
0.08 (0.05-0.18)
F1+2 (nmol/l) 1.57 (1.36-1.92) 2.13 (1.51-4.13)*** 1.55 (1.28-2.00)
1.66 (1.36-2.05)
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1001-12 Prevention of Flight-Related Thrombosis With Low-
Molecular Weight Heparin
Belcaro Giovanni, Maria Rosaria Cesarone, Andrew N. Nicolaides, George Geroulakos, 
Edmondo Ippolito, Michele Georgiev, Andrea Di Renzo, Mark Dougall, Morio Ashai, 
Steve Kakkos, The European Venous Forum, Lonflit Consortium and Chieti University, 
London, United Kingdom
The LONFLIT studies established that in high-risk subjects after long (> 10 hours) flights,
the incidence of deep venous thrombosis (DVT) is on average 3.6%. This study had eval-
uated prevention in high-risk subjects with low-molecular weight heparin (LMWH). Of 776
subjects contacted for the study, 458 were included and randomized, into three groups:
1) control group (no prophylaxis); 2) aspirin treatment group (0.4 g of oral, soluble aspirin;
one dose daily for 3 days, starting 12 hours before the beginning of the flight); 3) LMWH
group (4000 UI, dose of enoxaparine, between 2 and 3 hours before flights). Subjects
with potential problems due to prophylaxis with aspirin or LMWH were excluded. A total
of 422 subjects completed the study (dropouts were due to low compliance or travel ).
RESULTS. Age, sex and risk distribution were comparable in the groups. Mean age was
52 (range, 27-78; SD, 12; 63% males). Of the 142 controls (8) 5.6% had thrombotic event
(6 DVTs with two superficial thromboses). In the LMWH group (141 subjects), there were
no DVTs. In the aspirin group (139 subjects) there were 6 events (4.3%) with 4 DVTs.
DVT was asymptomatic in 68% of subjects and 93% of DVTs were observed in subjects
sitting in non-aisle seats. Mild gastrointestinal symptoms were reported in 11% of
patients taking aspirin. In conclusion one fixed dose of LMWH is an important option to
consider in high-risk subjects during long-haul flights.
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1001-13 Gender Bias Against Women: Men Receive Prophylaxis 
More Often to Prevent Deep Venous Thrombosis
Nils Kucher, David McKenzie, Rene Quiroz, Samy S. Mir, Ruth B. Morrison, Victor F. 
Tapson, Samuel Z. Goldhaber, for the DVT FREE Steering Committee, Brigham and 
Women's Hospital, Harvard Medical School, Boston, MA
We investigated gender differences in the prevention of acute deep venous thrombosis
(DVT). We used the database of DVT FREE, a prospective 183-center US registry of
5,451 consecutive patients (46.9% men, 53.1% women) with ultrasound-confirmed DVT.
Detailed information about DVT prophylaxis and medical comorbidities prior to the onset
of the acute DVT was available for 4,652 patients. Men more often than women (33.9%
vs. 29.1%; OR 1.22, 95% CI 1.08-1.38; p = 0.001) received mechanical or pharmaceuti-
cal prophylaxis 30 days prior to the onset of acute DVT. Multivariate adjustment for base-
line characteristics and DVT risk factors did not change this finding (Figure). Men were
20% more likely to receive prophylaxis (adjusted OR 1.20, 95% CI 1.03-1.41; p = 0.021).
Among 2,454 patients hospitalized at the time of DVT diagnosis, 53.5% of women and
46.5% of men had not received prophylaxis or treatment prior to the acute DVT (p =
0.042). When DVT prophylaxis was administered, the type of prophylaxis (66.9% vs.
66.3% pharmacological prophylaxis, 23.8% vs. 23.2% pneumatic compression devices,
16.7% vs. 16.4% vascular compression stockings) was similar between men and women.
Our most disturbing and provocative finding was identification of gender bias against
women: failure to administer DVT prophylaxis to high-risk women more than men who
subsequently developed acute DVT within 30 days. Future efforts should focus on
improved implementation of DVT prophylaxis guidelines among patients at high risk,
especially women.
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1001-14 A New Approach to Anticoagulation Therapy: The Fiscal 
and Quality Impact of Computerized Decision Support 
and Point of Care Testing
Mark W. Wurster, Bella Mehta, Jennifer Rodis, Trisha Doran, The Ohio State University, 
Columbus, OH
Background: Improved use of anticoagulation therapy has been identified as a priority
for the National Stroke Medicare Quality Improvement Project. Specialized anticoagula-
tion clinics have been shown to improve quality of care, but are limited by expense and
degree of expertise required. To address these issues, we evaluated a new approach to
anticoagulation therapy, utilizing Point of Care (POC) testing in combination with comput-
erized decision support (CDS).
Methods: As part of a National Institutes of Health supported study, two clinic systems
were examined with respect to approaches used for anticoagulation and clinical results
achieved. One system (patient control group, n=51) used a traditional approach consist-
ing of centralized laboratory testing, paper based record keeping and telephone contact.
Another system (patient test group, n=139) utilized an experimental approach combining
POC testing and CDS. Endpoints included: 1. Frequency of test results within therapeutic
range; 2. Documentation of treatment indication, INR goal, therapy duration, and testing
intervals; 4. Treatment related complications and costs; 5. Fiscal impact on participating
systems.
Results: Over a one-year period, test and control groups were compared with respect to
the endpoints listed. For the test group, INR compliance was 62%, compared to 38% for
the control group (p<0.01). Documentation of INR goal and indication for therapy were
100% for test patients, as opposed to 40% and 35% for controls, respectively. Compli-
ance with testing intervals was 86% for the test group, and 51% for controls (p<0.01).
The test group generated new revenue of $320.56 per patient per year, with labor related
overhead costs reduced by 74%. In the controls, 13 complications occurred, costing
$336,347.44. The test group experienced 4 complications, with costs totaling $225.00,
for a relative risk reduction of 89%, odds ratio = 0.11 (95% CI = 0.0352, 0.3622). Potential
cost savings totaled $6614.00 per patient.
Conclusion: An approach combining CDS and POC testing can significantly improve the
quality of care for patients on anticoagulation, while reducing system health care costs
and improving fiscal performance of providers.
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1001-15 Abnormal Calcium Handling and Focal Source 
Ventricular Fibrillation During Subacute Myocardial 
Infarction in Rabbits
Chung-Chuan Chou, Hideki Hayashi, Yen-Bin Liu, Echo Tan, Yong-Seog Oh, Michael C. 
Fishbein, Shien-Fong Lin, Peng-Sheng Chen, Cedars-Sinai Medical Center and David 
Geffen School of Medicine, UCLA, Los Angeles, CA
Background The relationship between intracellular calcium (Cai) transients and the
mechanisms of ventricular fibrillation (VF) during subacute MI is unclear.
Methods We created MI in 8 rabbits. The hearts were removed 5-7 days later, Langen-
dorff-perfused, and mapped simultaneously for membrane potential (RH237) and Cai
transients (Rhod-2) using two charge-coupled device cameras. Action potential duration
restitution (APDR) was determined by dynamic pacing protocol. Cytochalasin-D (5 µmol/
L) was used to suppress motion.
Results Size of MI was 27.2 ± 8.6 %. Cai transient alternans occurred in the peri-infarct
area at a longer pacing cycle length (PCL) than the non-infarcted area. The longest PCL
associated with Cai transient alternans was 218 ± 47 ms, which was associated with (2/
8) or without (6/8) concomitant Vm alternans at that site. The same site also had the
steepest maximum APDR slope (1.92 ± 0.90). During electrically induced VF, the same
area had the highest dominant frequency (18.1 ± 2.2 Hz) and the highest incidence of
wavebreaks. No stationary reentry was observed. The correlation coefficient between
dominant frequency in VF and the maximum slope of APDR curve was 0.81± 0.10 (p<
0.001). Among 20 ventricular premature beats (VPBs) arising from the peri-infarct area, 8
(40%) were preceded by spontaneous Cai oscillations and delayed afterdepolarizations.
Conclusions (a) High frequency focal sources are present in the peri-infarct area during
VF in a rabbit model of subacute MI. (b) Abnormal Cai transients, steep ADPR and multi-
ple wavebreaks are present at these high frequency focal sources of VF. (c) VPBs from
peri-infarct area are often induced by spontaneous Cai oscillations and delayed afterde-
polarizations.
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1001-16 Bipolar Radiofrequency Isolation of the Pulmonary 
Veins for Treatment of Atrial Fibrillation
A. Marc Gillinov, Patrick M. McCarthy, Eugene H. Blackstone, Gosta Pettersson, Royce 
Calhoun, Jennifer E. Cummings, Andrea Natale, Nassir Marrouche, The Cleveland Clinic 
Foundation, Cleveland, OH
Objectives: To determine safety and time-related clinical effectiveness of bipolar radiof-
requency isolation of the pulmonary veins in patients with symptomatic atrial fibrillation
(AF) undergoing open heart surgery.
Methods and Results: From November 2001 to April 2003, 134 patients underwent sur-
gical ablation of AF using a bipolar clamp (AtriCure®). Mean age was 68 years and 54%
were men.Median preoperative duration of AF was 24 months. AF was paroxysmal in
24%, persistent in 25% and permanent in 51%. Mean left atrial diameter was 5.4±0.96
cm. Patients were followed with Holter monitoring for a median of 5 days post OP. All
patients had bilateral pulmonary vein isolation and excision or exclusion of the left atrial
appendage and 44% had right atrial lesions. Mean ablation time was 16 minutes. More-
over Holter monitoring was conducted at 2, 3 and 6 months. Time-related prevalence of
AF was determined by nonlinear mixed-model data analysis with temporal decomposition
to accommodate different risk factors in different time frames, a novel technique. There
were no complications related to the pulmonary vein isolation using the bipolar clamp.
Long term Prevalence of AF decreased to 15% by 3 months after surgery (figure 1). Con-
clusions: From our preliminary experience intraoperative bipolar radiofrequency ablation
of AF seems to be rapid, safe and effective. Early postoperative AF is common, but does
not seem to predict long-term cure.
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1001-17 Cardiac Conduction System-L acZ Expression in the 
Atrioventricular Ring and Moderator Band of Transgenic 
Murine Embryos: A Developmental Substrate for Wolff-
Parkinson-White Syndrome and Mahaim Tachycardia?
Monique R.m Jongbloed, Martin J. Schalij, Robert E. Poelmann, Glenn I. Fishman, 
Zhiyong Wang, Adriana C. Gittenberger-de Groot, Leiden University Medical Center, 
Leiden, The Netherlands, New York University School of Medicine, New York, NY
Background: Atrioventricular and atriofascicular (Mahaim) fibers can cause ventricular
pre-excitation and sustain atrioventricular (AV)-re-entrant tachycardias, such as observed
in the Wolf-Parkinson-White (WPW) syndrome and Mahaim tachycardia. The morpholog-
ical substrate for initiation of these tachycardias has not been elucidated. The CCS(car-
diac conduction system)-lacZ construct is able to delineate the developing and mature
cardiac conduction system. The aim of this study was to examine the localization of the
developing AV conduction system in the CCS/lacZ reporter mouse, focusing on AV-con-
nections.
Methods: Analysis of lacZ-expression during sequential stages of cardiogenesis was
performed in a line of CCS-lacZ transgenic mice (E 9,5-15,5). Embryos were stained for
beta-galactosidase activity. Alternate sections were stained with the myocardial marker
HHF35 to produce a double staining with the reporter construct. Results were con-
structed into 3-D-images.
Results: Expression was observed in the sino-atrial node, left and right venous valves
and septum spurium, Bachman's bundle, the left atrial dorsal wall and in later stages sur-
rounding the pulmonary veins, the His bundle and bundle branches. Furthermore CCS-
lacZ expression was present in both the right and left atrioventricular ring, which became
fibrous in later stages. After formation of the right ventricular inlet component, CCS-lacZ
expression in the right ventricular moderator band was found to connect to the right bun-
dle branch and extended laterally up to connect to the right AV-ring. Thus a direct con-
